Phenotypic and genotypic characterization of multidrug-resistant Acinetobacter baumannii isolated in Algerian hospitals

Nabila Benamrouche; Ourida Lafer; Lahcen Benmahdi; Akila Benslimani; Wahiba Amhis; Houria Ammari; Farida Assaous; Amina Azzam; Kheira Rahal; Hassiba Tali Maamar

doi:10.3855/jidc.12348

Phenotypic and genotypic characterization of multidrug-resistant Acinetobacter baumannii isolated in Algerian hospitals

Authors

Nabila Benamrouche Medical Bacteriology Laboratory, Institut Pasteur of Algeria, Algiers, Algeria
Ourida Lafer Medical Bacteriology Laboratory, Institut Pasteur of Algeria, Algiers, Algeria
Lahcen Benmahdi University Regional Military Hospital of Oran, Oran, Algeria
Akila Benslimani Central Laboratory, Specialized Hospital Establishment Maouche Mohand Amokrane, Algiers, Algeria
Wahiba Amhis Central Laboratory, Public Hospital Establishment Ibn Ziri of Bologhine, Algiers, Algeria
Houria Ammari Central Laboratory, University Hospital of Beni Messous, Algiers, Algeria
Farida Assaous Medical Bacteriology Laboratory, Institut Pasteur of Algeria, Algiers, Algeria
Amina Azzam Microbiology and Parasitology Laboratory, University Hospital of Tizi Ouzou, Tizi Ouzou, Algeria
Kheira Rahal Medical Bacteriology Laboratory, Institut Pasteur of Algeria, Algiers, Algeria
Hassiba Tali Maamar Medical Bacteriology Laboratory, Institut Pasteur of Algeria, Algiers, Algeria

DOI:

https://doi.org/10.3855/jidc.12348

Keywords:

Multidrug-resistant Acinetobacter baumannii, blaCTX-M-15, blaSHV-33, blaNDM-1, colistin-resistance, Algeria

Abstract

Introduction: The aim of this study was to investigate the drug-resistance and the molecular characterization of carbapenemases, ESBL, and aminoglycoside-modifying enzymes among Acinetobacter baumannii clinical isolates in Algerian hospitals.

Methodology: A total of 92 A. baumannii isolates were collected between 2012 and 2016. Antimicrobial susceptibility testings were performed for β-lactams, aminoglycosides, fluoroquinolones, trimethoprim-sulfamethoxazole, rifampicin and colistin. The phenotypic characterization of β-lactamases was investigated. For 30 randomly targeted strains, the carriage of the carbapenemases, ESBL and aminoglycoside-modifying enzymes -encoding genes was determined by PCR. Sequencing was carried out for carbapenemases and ESBL genes.

Results: Most of the 92 isolates studied were recovered from hospitalized patients (93.5%) and were mainly from intensive care units (51.1%) and orthopedics (19.6%). The strains were collected primarily from low respiratory tract (33.7%), wounds (23.9%) and urine (16.3%). Multidrug-resistant A. baumannii strains were prevalent (96.7%). High rates of resistance were observed for almost all antibiotics tested (>70%) excluding rifampicin (7.6%) and colistin (5.4%). For the five colistin-resistant strains, MICs ranged between 4 and 128 µg/mL. Positive MBL (83.7%) and ESBL (23.9%) strains were identified. Regarding β-lactams, the bla_NDM and both bla_SHV and bla_CTX-M1 genes were detected in five and two strains respectively. Sequencing of the genes revealed the presence of bla_NDM-1, bla_CTX-M-15, and bla_SHV-33. For aminoglycosides, aac(6’)-Ib, ant(2’’)-I and aph(3’)-VI genes were detected in three, seven and six strains respectively.

Conclusions: Here, we report the first co-occurrence of extended-spectrum β-lactamases SHV-33 and CTX-M-15, the carbapenemase NDM-1 and the emergence of colistin-resistant A. baumannii in Algerian hospitals.

Downloads

Published

2020-12-31

How to Cite

Benamrouche N, Lafer O, Benmahdi L, Benslimani A, Amhis W, Ammari H, Assaous F, Azzam A, Rahal K, Tali Maamar H (2020) Phenotypic and genotypic characterization of multidrug-resistant Acinetobacter baumannii isolated in Algerian hospitals. J Infect Dev Ctries 14:1395–1401. doi: 10.3855/jidc.12348

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 14 No. 12: December 2020

Section

Original Articles

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).